Hjnnlnlknknmlk

MODULE: BM 6913 INTERNATIONAL BUSINESS AND TRADE

LECTURERS:

MICHAEL KEALY,

PAUL TAAFFE,

SHAUN HAYDEN

DATE : 2012-03-29

WORDCOUNT: 4,075

STUDENTS:

ANNA BRAKOWSKA 1110017

CIARA MAGUIRE 1647245

DENIS J O’DONOGHUE 1681649

TABLE OF CONTENTS

1. Introduction...................3

2. Finance..........................4-8

3. Operations......................9-11

4. Marketing.......................12-14

5. Conclusion......................15

6. Appendices......................16-21

7. Bibliography....................22-23

INTRODUCTION

This report provides financial analysis on the basis of profitability, liquidity, activity and financial structure ratios. It analyses and compares Pfizer’s current and past financial performance in contrast with one of Pfizer’s biggest competitors GlaxoSmithKline together with our recommendations for Pfizer’s future financial strategy which would enable the board of directors to make more informed decisions.

Within this report we aim to provide objective analysis of Pfizer’s current operations and how they could be improved to sustain and increase its market share.

( http://www.nyse.com/listed/pfe.html)

We aim to provide a possible strategy whereby Pfizer’s operations would have an opportunity to reinvent the way they do business in the future. In report we shall provide actionable recommendations to the processes which would allow for enhanced productivity and efficiency throughout the organisation.

We will discuss the target market that Pfizer serve and highlight the drawbacks and positives of their marketing technique, how it both hinders and enhances their performance as a company....